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Abstract Photoincorporation of the fluorescent probe 4,4'-
bis(l-anilino-8-naphthalene sulfonic acid) (bis-ANS) can be used 
to locate solvent-exposed hydrophobic regions in proteins. We 
show that bis-ANS is specifically incorporated into the putative 
N-terminal domain of aB-crystallin. This incorporation di-
minishes the chaperone-like activity of aB-crystallin, suggesting 
that hydrophobic surfaces in the N-terminal domain are involved 
in the binding of unfolding proteins. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The small heat shock proteins (hsp) form a large and di-
verse family of multimeric proteins, most of which can be 
induced by heat or other stress conditions [1-3]. The physio-
logical role of these proteins is rather unclear, but the fact that 
they share a chaperone-like property in vitro, i.e. the ability to 
stabilize aggregation-prone proteins [4,5], may be the key to 
gain insight into their in vivo functioning. Amongst the family 
of small hsp is the major eye lens protein a-crystallin, a mac-
romolecular complex comprised of two homologous types of 
subunits, aA- and aB-crystallin. Formerly, a-crystallin was 
believed to be strictly lens-specific, but now it is known that 
especially aB-crystallin is expressed in a variety of non-lentic-
ular tissues [6,7]. In addition, increased levels of aB-crystallin 
have been found in several neurodegenerative disorders [8-11]. 
In the absence of any X-ray crystal data, little is known 
about the tertiary and quaternary structure of a-crystallin. 
Intron positions in the a-crystallin genes suggested a tertiary 
structure consisting of two domains and an extending C-ter-
minal arm [12]. Experimental support for this structure comes 
from unfolding studies and NMR-analysis [13,14]. The ar-
rangement of the subunits in the multimeric complex is sub-
ject of controversy, because the experimental data are equiv-
ocal and contradictory. 
Probe-binding studies have shown that a-crystallin, unlike 
ß- and y-crystallins, is very rich in solvent-exposed hydropho-
bic regions [15]. These regions are apparently responsible for 
the ability of a-crystallin to prevent protein aggregation 
[16,17], by having affinity for the molten globule state of un-
folding proteins [18,19]. Heterocomplexes formed between a-
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crystallin and molten globules are even more hydrophobic 
than a-crystallin itself, but nevertheless they are stable and 
do not precipitate [19,20]. The high solubility of these hetero-
complexes may be attributable to the solvent exposed C-ter-
minal arms of the a-crystallin subunits [21]. Deletion of the C-
terminal 17 residues from human aA-crystallin results indeed 
in a marked reduction of chaperone-like activity [22] 
The amino acid residues of a-crystallin which constitute the 
hydrophobic surface regions are unknown. The fluorescent 
probe 4,4'-bis(l-anilino-8-naphthalene sulfonic acid) (bis-
ANS) has frequently been used to monitor changes in hydro-
phobic surfaces in various proteins, including a-crystallin 
[17,23]. Recently this probe was also used to determine the 
actual location of solvent-exposed hydrophobic regions in the 
bacterial chaperone GroEL [24]. It was shown that photo-
induced incorporation of bis-ANS specifically occurs in the 
apical domain of GroEL-subunits, which is indeed the binding 
site for misfolded proteins [25,26]. In this paper we similarly 
use bis-ANS to determine whether the N-terminal or C-termi-
nal domain of aB-crystallin is potentially involved in the 
binding of unfolding proteins. 
2. Materials and methods 
2.1. Materials 
A pET3a cDNA-construct encoding rat aB-crystallin was trans-
formed in the host Escherichia coli B BL21(DE3)pLysS [27]. Induc-
tion, purification and reconstitution of aB-crystallin were performed 
as described before [28]. Cyanogen bromide and bovine pancreas in-
sulin were obtained from Sigma. Sephadex G-50 gel permeation ma-
terial was purchased from Pharmacia Biotech and 4,4'-bis(l-anilino-8-
naphthalene sulfonic acid) dipotassium salt was obtained from Mo-
lecular Probes. 
2.2. Photoincorporation 
A solution of aB-crystallin (300 ug) and bis-ANS (50 nmol) in 1 ml 
of 20 mM NaPj, 100 mM Na2S04, pH 6.9, was exposed to laboratory 
strip lighting for 30 min at ambient temperature. A control sample 
without bis-ANS was given the same treatment. Salts and non-bound 
bis-ANS were removed by applying the samples to a Sephadex G-50 
spin column (pre-equilibrated with water) followed by dialysis against 
water. Subsequently, the solutions were lyophilized. The color of aB-
crystallin incubated with bis-ANS was yellow, indicating incorpora-
tion of the fluorescent probe. The incorporation efficiency could be 
slightly increased by using a 366 nm UV light source (Ultra Violet 
Products, UVL-56) instead of strip lighting. However, exposure to 
long wave UV radiation also resulted in a certain amount of unde-
sired protein crosslinking. 
2.3. Cyanogen bromide cleavage 
A cyanogen bromide solution was prepared by adding a few crys-
tals of cyanogen bromide to 200 u.1 of formic acid. The lyophilized 
protein samples were dissolved in 30 ul of the cyanogen bromide 
solution and incubated overnight at room temperature. To check 
whether the acidic conditions alone induce protein cleavage, control 
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samples were incubated in formic acid without cyanogen bromide [29]. 
Afterwards, the formic acid was evaporated in a Speed Vac Concen-
trator (Savant, SVC-100H) and the protein residues were dissolved in 
tricine-SDS-PAGE sample buffer. 
2.4. Chaperone assay 
Samples of aB-crystallin (900 ug in 1 ml), incubated with and with-
out bis-ANS (150 nmol), were applied to a Sephadex G-50 spin col-
umn (pre-equilibrated with 20 mM NaPj, 100 mM Na2S04, pH 6.9). 
Afterwards, the volume of the samples was measured and adjusted to 
precisely match the protein concentrations. Chaperone-like activity 
was determined essentially as described by Farahbakhsh et al. [30]. 
Briefly, aB-crystallin (54 or 216 ug) was pre-incubated with 245 ug 
bovine pancreas insulin for 3 min at 40°C. Denaturation of insulin 
was initiated by addition of 20 ul of 1 M dithiothreitol, and scattering 
was monitored for 15 min at 360 nm using a Perkin-Elmer Lambda 2 
UV/VIS spectrophotometer equipped with a thermostated circulating 
water bath at 40°C and a thermocouple to register the sample temper-
ature. Total volume was 1.0 ml, and all solutions were in 20 mM 
NaPi, 100 mM Na2S04, pH 6.9. 
2.5. Miscellaneous methods 
The concentration of bis-ANS stock solutions in 20 mM NaPi, 100 
mM Na2SC>4, pH 6.9, was determined by measuring the absorbance at 
385 nm (e385 = 16790 M _ 1 cm- 1) [31]. Protein concentrations were 
determined in triplicate using the Bradford assay [32]. Gel permeation 
analysis was performed on a Superose 6 HR 10/30 prepacked column 
(Pharmacia Biotech) as described before [28]. High molecular mass 
standards (Pharmacia Biotech) were used for calibration. Protein sam-
ples were analyzed by tricine-SDS-PAGE [33]. Photolabeled proteins 
were visualized on a UV light box equipped with a video camera 
(Biorad Geldoc 1000). The data were processed with Molecular An-
alyst 1.2 software (Biorad). 
3. Results and discussion 
Rat aB-crystallin has a length of 175 amino acid residues. 
The putative N-terminal domain comprises residues 1-67 [12] 
The putative C-terminal domain and C-terminal arm are 
formed by residues 68-175. The demarcation of the C-termi-
nal arm is not completely clear, but according to NMR-anal-
ysis only residues 166-175 have great flexibility [34]. 
Hydropathy analyses suggested that the N-terminal domain 
is on average more hydrophobic than the C-terminal domain 
[35,36]. However, this does not imply that the N-terminal 
domain is directly involved in protein binding. The apolar 
residues of this domain may constitute a non-exposed hydro-
phobic core contributing to structural stability rather than a 
solvent-accessible hydrophobic surface. Furthermore, as illus-
trated by the Kyte-Doolittle plot in Fig. 1, the C-terminal 
domain may comprise a few regions which are at least as 
hydrophobic as the N-terminal domain. 
To discriminate between the N-terminal and C-terminal 
domain as potential substrate binding region, purified rat 
aB-crystallin was incubated with bis-ANS and photolabeling 
was induced by exposure to laboratory strip lighting. Subse-
quently, the non-bound bis-ANS was removed and the photo-
labeled aB-crystallin was subjected to cleavage with cyanogen 
bromide. Rat aB-crystallin contains three methionine resi-
dues, one at the N-terminus and the other two precisely at 
the boundary between the two putative domains, i.e. at posi-
tions 68 and 70. Therefore, reaction with cyanogen bromide 
should result in a 8 kDa fragment comprising the N-terminal 
domain and a 12 kDa fragment comprising the C-terminal 
domain and C-terminal arm. The cleavage products were an-
alyzed via tricine-SDS PAGE. The protein patterns after 
Coomassie Brilliant Blue staining are shown in Fig. 2A. 
Lane 2 displays control aB-crystallin and lane 1 shows that 
CD 
T3 
C-termina! domain 
50 75 100 125 
residue position 
175 
Fig. 1. Hydropathy plot of rat aB-crystallin. The hydropathy index 
was calculated for segments of six residues according to the method 
of Kyte and Doolittle [42], The hydropathy index of each segment 
is plotted as a function of its location in the primary structure. The 
hydropathy profile of the C-terminal domain is highly conserved in 
the small hsp family [2]. 
reaction of this protein with cyanogen bromide results in the 
formation of two new polypeptide bands. The estimated mo-
lecular masses of these cleavage fragments were as expected, 
i.e. 8 and 12 kDa. Furthermore, lane 1 also exhibits some 
uncleaved aB-crystallin indicating that the reaction did not 
proceed to completion. Lane 4 displays aB-crystallin incu-
bated with bis-ANS and lane 3 shows that cleavage of this 
sample proceeds nearly as efficiently as cleavage of control 
aB-crystallin (compare lanes 3 and 1). The fluorescence gel 
shown in Fig. 2B corresponds to the stained gel in Fig. 2A 
and visualizes the polypeptides which have incorporated the 
bis-ANS probe. As expected, cleaved and uncleaved control 
aB-crystallin are not discernible on this gel (lanes 1 and 2, 
respectively). However, the fluorescent band in lane 4 clearly 
demonstrates that aB-crystallin becomes photolabeled upon 
incubation with bis-ANS. In addition, lane 3 shows that this 
photolabeling is restricted to the N-terminal domain, because 
only the 8 kDa cleavage fragment is fluorescent. Thus the N-
terminal domain, but not the C-terminal domain exposes hy-
drophobic surfaces which are able to covalently bind the hy-
drophobic probe bis-ANS. 
The bis-ANS probe is a small aromatic molecule with a 
molecular mass of only 673 Da. In contrast, the usual protein 
substrates of a-crystallins have molecular masses which are at 
least several kilodaltons. Hence, the binding sites for bis-ANS 
in aB-crystallin may not or only partially coincide with the 
binding sites for protein substrates. However, if the bis-ANS 
probe is actually bound to hydrophobic surfaces involved in 
protein binding, photolabeling of aB-crystallin is likely to 
diminish chaperone-like activity. That is to say, the binding 
sites may loose their affinity for unfolding substrates upon 
irreversible crosslinking to bis-ANS. To determine the influ-
ence of bis-ANS incorporation on chaperone-like activity, 
photolabeled and control aB-crystallin were assayed for their 
ability to prevent the chemically-induced aggregation of insu-
lin B-chains. Reduction of the disulfide bonds between the A-
and B-chain of insulin, results almost instantaneously in a 
precipitation of the B-chains. Fig. 3 shows that this event 
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Fig. 2. Photoincorporation of bis-ANS into aB-crystallin. A: Coomassie Brilliant Blue stained tricine-SDS gel. B: Corresponding fluorescent 
gel. Molecular mass markers (M in kDa) are indicated. Samples are: control aB-crystallin cleaved with cyanogen bromide (lane 1), uncleaved 
control aB-crystallin (lane 2), photolabeled aB-crystallin cleaved with cyanogen bromide (lane 3), uncleaved photolabeled aB-crystallin (lane 4). 
The uncleaved samples (lanes 2 and 4) display two minor components below the main band. These components are most probably products of 
truncation caused by the incubation in formic acid (see Section 2). 
can easily be monitored by measuring the absorbance at 360 
nm. Insulin was reduced at aB-crystallin to insulin mass ratios 
of 22% and 88%, respectively. Comparison of the aggregation 
profiles in Fig. 3 clearly demonstrates that at both ratios the 
activity of photolabeled aB-crystallin is considerably lower 
than that of control aB-crystallin. Thus, incorporation of 
bis-ANS into aB-crystallin decreases its ability to suppress 
aggregation of insulin B-chains. Although this result suggests 
that bis-ANS indeed interacts with functional protein binding 
sites, other explanations cannot be excluded. For example, 
incorporation of bis-ANS may affect the structure of aB-crys-
tallin, resulting in a lower functional activity. However, gel 
permeation analysis does not support that a major conforma-
tional change is induced by bis-ANS incorporation. Like con-
trol aB-crystallin, photolabeled aB-crystallin élûtes as a reg-
ular multimeric complex with a molecular mass of about 670 
kDa (data not shown). 
The specific binding of bis-ANS to the N-terminal domain 
of aB-crystallin is in agreement with the hydropathy analyses 
[35,36], that is, the N-terminal domain is indeed more hydro-
phobic than the C-terminal domain. Furthermore, binding of 
the soluble bis-ANS probe suggests that the N-terminal do-
main is at least partially solvent-exposed in the multimeric 
aB-complex. Other evidence for an accessible N-terminal do-
main comes from phosphorylation studies. The phosphoryla-
tion sites in bovine aB-crystallin are located in the N-terminal 
domain at serine positions 19, 45 and 59 [37,38]. These sites 
are conserved in rat aB-crystallin and indicate that the N-
terminal domain is sufficiently exposed to enable interaction 
with kinases. Our data suggest that the binding sites for bis-
ANS and substrate proteins at least partially coincide. It thus 
appears that the N-terminal domain of aB-crystallin is in-
volved in substrate binding, and therefore essential for activ-
ity. This conclusion is in agreement with the findings of Smith 
et al. [39], who propose on basis of hydrogen-deuterium ex-
change experiments that residues 28-34 in bovine aB-crystal-
lin constitute a possible substrate binding region. Recently, 
hspl8.1 from pea was subjected to photolabeling, and incor-
poration of bis-ANS was found in the extreme N-terminal 
region as well as in a region of the C-terminal domain [40]. 
The latter region was proposed to be critical for chaperone-
like activity because it is highly conserved among plant small 
hsp. However, we show that the corresponding region in rat 
aB-crystallin, i.e residues 79-96, does not incorporate bis-
ANS at a detectable level. 
Members of the small hsp family share two important fea-
tures; they occur as dynamic multimeric complexes and they 
can bind unfolding proteins. These features are likely to be 
related, i.e. multimerization of small hsp subunits may be 
nature's solution to create a very stable and soluble complex 
with a high capacity for preventing substrate proteins from 
aggregation. The C-terminal domain of small hsp subunits is 
much more conserved during evolution than the N-terminal 
domain [2,12]. Although it seems contradictory to associate 
functional activity with a relatively non-conserved region, it 
should be realized that chaperone-like activity is a non-specific 
phenomenon. The functional sites of small hsp must be able 
to bind a variety of substrate proteins, and therefore their 
amino acid sequence may be subject to variation as long as 
hydrophobic surfaces are preserved. In contrast, multimeriza-
tion may require rather defined structural elements that do 
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Fig. 3. Chaperone-like activity of control and photolabeled aB-crys-
tallin. Reduction-induced aggregation of insulin (245 ug/ml) a s a 
function of time in the absence and presence of aB-crystallin (54 or 
216 |j.g/ml; 22% or 88% mass ratios). The incubation temperature 
was 40°C and the reduction of insulin was initiated by addition of 
20 ul of 1 M dithiothreitol. 
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not allow much sequence change, as is the case in the C-
terminal domain. 
The present results indicate that the N-terminal domain of 
aB-crystallin has solvent-accessible hydrophobic regions. 
Moreover, other studies have shown that the flexible C-termi-
nal arm as well as parts of the C-terminal domain are suscep-
tible for enzymatic post-translational modifications [41]. Thus, 
whatever the quaternary structure of aB-crystallin may be, the 
subunits are likely to have an orientation which allows both 
domains to be accessible for either unfolding proteins or mod-
ifying enzymes. 
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